一名非IHF患者先前接受过植入式心律转复除颤器(ICD)治疗。用于心脏再同步化治疗(CRT)的ICD和装置在基线时的植入对于非IHF和IHF是相似的[ICD:non-IHF 4.9%vs.IHF 0.9%(P=0.105),CRT:non-IHF 3.0%vs.IHF1.8%(P=0.716)]。基线...
With SSS, the heart rate can alternate between slow (bradycardia) and fast (tachycardia), often in combination with atrial fibrillation or atrial flutter. Treatment of SSS may involve a pacemaker and/or medication. View Answer Therapy options Therapy options Learn about related therapy options....
A cavotricuspid isthmus-dependent flutter with an unexpected left atrial activation sequence: A case report Randa Tabbah, Bernard Abi-Saleh Published: 24/10/2024 DOI: 10.24969/hvt.2024.522 Full Text | PDF CASE REPORT Severe, rapidly evolving infective endocarditis as a complication of elective...
This document does not man-date assessment of all these comorbidities, rather sets out how they should be defined if they are assessed, including anaemia and iron deficiency, atrial fibrillation (AF) and atrial flutter, cachexia, chronic obstructive pulmonary disease, coronary artery disease, ...
TheAtrial fibrillationcluster is named for the high prevalence ofatrial fibrillation(95.7% of patients) and its many variants, includingatrial fibrillation and flutter,paroxysmal atrial fibrillation,permanent atrial fibrillation, persistent atrial fibrillation, among others, and other signs of arrhythmia, inc...
Although electrical cardioversion can be used to treat almost any abnormal fast heartbeat (such as atrial flutter and ventricular tachycardia), it is used most frequently to convert atrial fibrillation to a normal rhythm. Anticoagulants such as rivaroxaban (Xarelto), apixaban (Eliquis), and warfarin...
Tachyarrhythmias , such as nonsustained ventricular tachycardia (NSVT) and atrial fibrillation and flutter (AF), impact right atrial function. In AF, atrial contraction is reduced leading to a decrease in ventricular filling and stroke volume. In NSVT, the systolic volume is diminished due to atri...
Atrial fibrillation/flutter 1.05 (1.05–1.06) Myocardial infarction 1.07 (1.06–1.07) Hyperlipidemia 0.948 (0.943–0.952) Peripheral vascular disease 1.00 (0.995–.01) Stroke/TIA 0.991 (0.983–0.999) Diabetes 0.993 (0.989 - 0.997) Obesity 0.940 (0.937–0.943) Chronic renal failure 1.08 (1.07–1.08...
and had an N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration of at least 600 pg/mL (≥400 pg/mL if hospitalized for HF within the previous 12 months and ≥900 pg/mL if atrial fibrillation/flutter irrespective of history of HF hospitalization) (to convert to nanograms per...
The primary outcome endpoint was the occurrence of heart failure and ventricular arrhythmia composite, which consisted of VT, ventricular flutter, and VF. People who underwent nationwide health check-ups in 2009 were divided into two groups: (1) those diagnosed with PVC in 2009 and (2) those ...